Strategic Objectives
• Master the mechanics of viral and non-viral delivery systems.
• Understand how CRISPR and RNA interference silence deadly mutations.
• Explore the cutting-edge of non-invasive blood-brain barrier bypass.
• Gain insights into the clinical landscape of FDA-approved genetic cures.
The Core Challenge
For decades, neurodegenerative diseases like Huntington’s and ALS have been considered death sentences with no hope of a cure.
01
The Genetic Architecture of Decay
02
Foundations of Gene Therapy
03
The Workhorse: Adeno-Associated Virus
04
Lentiviral Vectors
05
Non-Viral Delivery Systems
06
Breaching the Fortress
07
Precision Editing with CRISPR
08
RNA Interference
09
The Challenge of Parkinson’s Disease
10
Targeting Alzheimer’s Disease
11
Conquering Huntington’s Disease
12
Amyotrophic Lateral Sclerosis (ALS)
13
Spinal Muscular Atrophy
14
Promoter Design and Control
15
The Immune Response Barrier
16
Neuroethics and Genetic Modification
17
Route of Administration
18
Clinical Trial Design
19
Regulatory Pathways
20
Manufacturing at Scale
21